Vulvar Vestibulitis Completed Phase 1 Trials for Lidocaine (DB00281)

Also known as: Vestibulodynia / Vulval vestibulitis

IndicationStatusPhase
DBCOND0001344 (Vulvar Vestibulitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01996384Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot StudyTreatment